The AI in Business Podcast cover image

AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

The AI in Business Podcast

00:00

Transforming Regulatory Functions with Generative AI in Drug Development

The chapter explores the challenges and considerations of using generative AI in drug development, emphasizing the need for human oversight for accuracy and compliance. It discusses the potential of generative AI to revolutionize regulatory functions in pharmaceutical R&D. The importance of combining domain expertise with AI knowledge and preparing employees for AI adoption is highlighted.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app